For the year ending 2025-12-31, AIDX has $4,137,357 in assets. $4,156,582 in debts. $1,025,987 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,025,987 | |||
| Accounts receivable, net | 199,954 | |||
| Inventory | 116,217 | |||
| Prepaid expenses and other current assets | 128,975 | |||
| Total current assets | 1,471,133 | |||
| License agreement, net | 271,143 | |||
| Property and equipment, net | 56,677 | |||
| Intangible assets, gross | 243,644 | |||
| Less accumulated amortization | 41,380 | |||
| Intangible assets, net | 202,264 | |||
| Right-of-use asset, net | 605,289 | |||
| Deferred offering costs | 1,507,794 | |||
| Other assets | 23,057 | |||
| Total assets | 4,137,357 | |||
| Accounts payable | 868,545 | |||
| Accrued liabilities | 785,784 | |||
| Deferred revenue | 414,871 | |||
| Derivative liability | 143,382 | |||
| Convertible note | 74,611 | |||
| Operating lease liability current | 175,948 | |||
| Total current liabilities | 2,463,141 | |||
| Convertible notes payable, net | 619,355 | |||
| Deferred revenue long-term | 41,816 | |||
| Derivative liabilities long-term | 543,545 | |||
| Operating lease liability long term | 488,725 | |||
| Total long-term liabilities | 1,693,441 | |||
| Total liabilities | 4,156,582 | |||
| Preferred stock value-Series DPreferred Stock | 1,016 | |||
| Preferred stock value-Series CPreferred Stock | 12,040 | |||
| Preferred stock value-Series BPreferred Stock | 14,715 | |||
| Preferred stock value-Series A2Preferred Stock | 4,424 | |||
| Preferred stock value-Series A1Preferred Stock | 6,515 | |||
| Preferred stock value-Series APreferred Stock | 8,464 | |||
| Common stock, 0.01 par value 50,000,000 authorized 5,442,249 and 4,823,125 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 54,422 | |||
| Additional paid-in capital | 33,126,398 | |||
| Accumulated deficit | -33,247,219 | |||
| Total stockholders (deficit) equity | -19,225 | |||
| Total liabilities and stockholders equity | 4,137,357 | |||
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)